Neurology

While previous research has shown that following a Mediterranean-style diet could have protective effects for stroke, little information on how this effect could differ by sex or cardiovascular disease risk...

New research suggests that as persons with MS age, their quality of life and severity of depression change.

New research points to an association between X-linked Charcot-Marie-Tooth disease and MS.

The FDA has approved a new migraine injection available in weekly and monthly dosing options.

Researchers evaluated the value of neurofilament light chain levels as a cerebrospinal fluid or blood biomarker in patients with MS.

Researchers have discovered a new subtype of MS, providing a better understanding of the nature of the disease.

The FDA has approved a new drug for the treatment of seizures associated with Dravet syndrome, a rare form of epilepsy.

New data on nearly 71,000 patients with Alzheimer disease point toward a potential association between Alzheimer risk and the use of commonly prescribed treatments for anxiety, insomnia, and related...

Discontinuing disease-modifying therapies is common among patients with MS but can increase the risk of progression or relapse.

The US Food and Drug Administration has granted approval to the first treatment in a new drug class for a nerve condition that affects about 50,000 people worldwide.